Allarity Therapeutics, Inc. (ALLR)
$0.99+1.02%Close
SELLCRISIS · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $16M
- Beta
- 0.57
- P/E (TTM)
- -1.26
- Short % float
- 0.98%
- Days to cover
- 1.0
- SI change
- +6.5%
- 1W
- -4.81%
- 1M
- -20.80%
- vs SPY 1W
- -5.97%
- vs SPY 1M
- -23.79%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ALLR?
- LOPJLB’s latest quantitative signal on Allarity Therapeutics, Inc. (ALLR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ALLR in?
- Allarity Therapeutics, Inc. (ALLR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Allarity Therapeutics, Inc. (ALLR) do?
- Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics. The company's portfolio of investigational drugs for various cancers includes: Sten…